Members of the Commons health committee voted 6-5 vote to reject public disclosure of a contract issued to a failed Quebec vaccine supplier. Conservative MP Rick Perkins said scant records show ...

Japanese pharmaceutical giant Mitsubishi Tanabe Pharma Corp. announced that a COVID-19 vaccine derived from a type of tobacco plant and developed by Medicago Inc., the Osaka-based company’s ...

So Medicago, a clinical-stage biopharmaceutical company located in Quebec, Canada, is harnessing a plant-based transient expression process to produce pharmaceutical-grade proteins in a matter of ...

That holds doubly true for Medicago, a Canadian biopharma company. Medicago uses plants to produce vaccine and therapeutic candidates, and the platform has found new purpose in the age of coronavirus.

More information: Liangliang He et al, GRAS transcription factor PINNATE-LIKE PENTAFOLIATA2 controls compound leaf morphogenesis in Medicago truncatula, The Plant Cell (2024). DOI: 10.1093/plcell ...